The risk of breast cancer related to CD44 rs13347 genotypes were further examined with stratification by age, age at menarche, menstrual history, BMI and family history of breast cancer, pathological type, clinical stage, estrogen receptor status and progesterone receptor status. This evidence concerns the gene CD44 and breast carcinoma.